Matt Brokaw, CEO
Aerin Medical is a commercial stage ENT medical device company that has developed a unique, noninvasive platform technology for the treatment of nasal airway disorders.
“Aerin Medical is primed for its next phase of growth, propelled by non-invasive treatments and in-office procedure options that are increasingly important.”
Matt Brokaw
CEO
Their story
Nasal airway obstruction (NAO) and chronic rhinitis (CR) are among the most common complaints in ENT offices, often leading to reduced overall health, poor sleep quality, and a diminished quality of life. Traditional treatments — ranging from invasive surgical procedures to long-term drug therapies — can be costly, require extensive recovery, and come with significant side effects.
Aerin Medical was founded to expand access to meaningful relief for millions of patients suffering from chronic ENT conditions. By partnering with physicians, Aerin Medical delivers innovative technologies that offer appealing alternatives to invasive surgery. To date, more than 150,000 patients have been treated with Aerin Medical products.
.avif)
Our partnership
Our relationship with Aerin Medical began years before our initial investment. Ryan first met CEO Matt Brokaw during his time at Acclarent, where Ryan was a deep and early-stage investor.
We also knew the existing board well and since investment, we have been able to further surround the company with additional strategic support and guidance by adding an independent board member with deep industry experience who had served as CEO of a previous ENT investment made at a predecessor firm.
The team involved
.avif)